As illustrated in the PPI network, CXCR4 as a chemokine receptor has been found to be upregulated in cancer metastasis, and it has been used as a prognostic marker in various types of cancer, including leukemia, breast cancer, and prostate cancer [35–37]. Here, CXCR4 is linked to cancer.